Annual Report

Overview

The report describes 2019 as a successful operational and strategic year, marked by new partnerships with pharmaceutical, biotech and foundation partners. It highlights Evotec's expansion into biologics through the acquisition of Just Biotherapeutics and the formation of the NephThera joint venture with Vifor Pharma. Consolidated group revenues reached 446,437 T€ in 2019, including material recharges.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Publication date: 26 March 2020
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services